HAUSP inhibitors constitute a group of compounds designed to modulate the activity of HAUSP, a deubiquitinating enzyme crucial in regulating the stability of key proteins involved in cell cycle control and apoptosis. These inhibitors include both direct inhibitors, which specifically target HAUSP's enzymatic activity, and indirect inhibitors, which influence HAUSP's function through modulation of related pathways or enzymatic processes. Compounds such as P22077, HBX 41,108, FT671, and XL177A are direct inhibiitors of HAUSP. These inhibitors specifically target HAUSP's deubiquitinase activity, thereby disrupting its role in the stabilization of specific proteins, notably MDM2 and p53. P22077, for instance, directly inhibits HAUSP, leading to the stabilization of p53 and the induction of apoptosis, a crucial process in maintaining cellular homeostasis. HBX 41,108 and FT671 operate similarly, blocking HAUSP from deubiquitinating and stabilizing MDM2, thus allowing p53 to promote apoptotic pathways. XL177A also targets HAUSP, contributing to increased p53 activity and impeding cell proliferation, a mechanism particularly relevant in cancer cells where HAUSP is often overexpressed.
Compounds like Spautin-1, WP1130, NSC632839, PR-619, IU1, b-AP15, SJB2-043, and ML323 are indirect inhibitors of HAUSP. These inhibitors do not target HAUSP directly but rather modulate the ubiquitination landscape within cells, thereby influencing HAUSP's functional role. Spautin-1, by promoting the degradation of USP10 and USP13, indirectly impacts HAUSP's activity in protein stabilization. WP1130 and NSC632839, as broad-spectrum DUB inhibitors, alter the stabilization and signaling pathways of various proteins, indirectly affecting HAUSP-regulated processes. IU1 and b-AP15, targeting other specific deubiquitinases, influence the proteasome-associated deubiquitinase activity, thus impacting the protein degradation pathways in which HAUSP is involved. Collectively, HAUSP inhibitors, both direct and indirect, represent a critical tool in modulating the activity of HAUSP. By influencing the stability and function of various proteins, these inhibitors can significantly impact key cellular processes, including cell cycle regulation, apoptosis, and protein turnover.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
P22077 | 1247819-59-5 | sc-478536 | 10 mg | $165.00 | ||
A specific inhibitor of USP7/HAUSP, P22077 directly inhibits its deubiquitinase activity. This leads to the stabilization of p53 and promotes apoptosis, as HAUSP normally deubiquitinates and stabilizes MDM2, a negative regulator of p53. | ||||||
Spautin-1 | 1262888-28-7 | sc-507306 | 10 mg | $168.00 | ||
A compound that promotes the degradation of USP10 and USP13, indirectly affecting HAUSP activity. By destabilizing these USPs, Spautin-1 can alter protein ubiquitination dynamics, indirectly impacting HAUSP-regulated pathways. | ||||||
WP1130 | 856243-80-6 | sc-364650 sc-364650A | 10 mg 50 mg | $490.00 $1484.00 | 1 | |
A deubiquitinase inhibitor that targets multiple DUBs, including USP9x, USP5, USP14, and UCH37, indirectly affecting HAUSP function. WP1130 disrupts protein stabilization and signaling pathways regulated by these DUBs, which can influence HAUSP's role in protein turnover. | ||||||
PR 619 | 2645-32-1 | sc-476324 sc-476324A sc-476324B | 1 mg 5 mg 25 mg | $77.00 $188.00 $431.00 | 1 | |
A broad-spectrum DUB inhibitor, PR-619 indirectly influences HAUSP activity by altering overall ubiquitination patterns within cells, which can affect HAUSP-mediated protein stabilization. | ||||||
IU1 | 314245-33-5 | sc-361215 sc-361215A sc-361215B | 10 mg 50 mg 100 mg | $138.00 $607.00 $866.00 | 2 | |
While specifically inhibiting USP14, IU1 can indirectly affect HAUSP by altering the ubiquitination and degradation of proteins within the proteasome, potentially influencing HAUSP-regulated cellular processes. | ||||||